🇺🇸 FDA
Pipeline program

Pulse Sequence

16-044

Approved other completed

Quick answer

Pulse Sequence for Atrial Fibrillation is a Approved program (other) at Aspire Biopharma Holdings with 1 ClinicalTrials.gov record(s).

Program details

Company
Aspire Biopharma Holdings
Indication
Atrial Fibrillation
Phase
Approved
Modality
other
Status
completed

Clinical trials